• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Skye Bioscience, Inc. - Common Stock (NQ:SKYE)

    0.7730 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,314
    Open 0.7730
    Bid (Size) 0.7451 (200)
    Ask (Size) 0.8100 (100)
    Prev. Close 0.7730
    Today's Range 0.7730 - 0.7730
    52wk Range 0.5655 - 5.750
    Shares Outstanding 417,247,333
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    These stocks have an unusual volume in today's session ↗
    Via Chartmill
    What's going on in today's pre-market session ↗
    Via Chartmill

    Performance

    YTD
    -12.0%
    -12.0%
    1 Month
    +8.0%
    +8.0%
    3 Month
    -24.2%
    -24.2%
    6 Month
    -49.5%
    -49.5%
    1 Year
    -54.8%
    -54.8%

    More News

    Read More
    Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
    Via Chartmill
    News headline image
    SKYE DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important January 16 Deadline in Securities Class Action – SKYE
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    SKYE BIOSCIENCE FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Skye Bioscience, Inc. Stockholders to Contact the Firm Before January 16th
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Skye Bioscience, Inc. (NASDAQ: SKYE) Investors to Inquire About a Securities Fraud Class Action by January 16, 2026
    From Berger Montague
    Via GlobeNewswire
    News headline image
    SKYE DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important January 16 Deadline in Securities Class Action – SKYE
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    SKYE BIOSCIENCE CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urgently Reminds Skye Bioscience, Inc. Stockholders to Contact the Firm Before January 16th
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    SKYE Deadline: Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders to Contact the Firm for Information About Their Rights
    From The Rosen Law Firm, P.A.
    Via Business Wire
    News headline image
    SKYE INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    SKYE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Skye Bioscience, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    NASDAQ: SKYE INVESTOR ALERT: Berger Montague Advises Skye Bioscience, Inc. (NASDAQ: SKYE) Investors of a January 16, 2026 Deadline
    From Berger Montague
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Which stocks are moving after the closing bell on Tuesday? ↗
    Via Chartmill
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    SKYE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire

    Frequently Asked Questions

    Is Skye Bioscience, Inc. - Common Stock publicly traded?
    Yes, Skye Bioscience, Inc. - Common Stock is publicly traded.
    What exchange does Skye Bioscience, Inc. - Common Stock trade on?
    Skye Bioscience, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Skye Bioscience, Inc. - Common Stock?
    The ticker symbol for Skye Bioscience, Inc. - Common Stock is SKYE on the Nasdaq Stock Market
    What is the current price of Skye Bioscience, Inc. - Common Stock?
    The current price of Skye Bioscience, Inc. - Common Stock is 0.7730
    When was Skye Bioscience, Inc. - Common Stock last traded?
    The last trade of Skye Bioscience, Inc. - Common Stock was at 04/15/26 04:00 PM ET
    What is the market capitalization of Skye Bioscience, Inc. - Common Stock?
    The market capitalization of Skye Bioscience, Inc. - Common Stock is 322.53M
    How many shares of Skye Bioscience, Inc. - Common Stock are outstanding?
    Skye Bioscience, Inc. - Common Stock has 323M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.